Dan Chapman Email Address

Head of Information Technology New Medicines Information Management

UCB Pharma, a biopharmaceutical and specialty chemical company, develops therapeutics for central nervous system and immunological diseases.

Dan Chapman, PhD, leads the IT New Medicines Information (NMIM) Management group at UCB. Dr. Chapman’s team is driven to create an enabling environment of data that will help the scientific community derive better insights and promote data driven decisions. A core belief of the NMIM team is that the use of innovative technologies will lead to improved processes and support more efficient research. The responsibilities of the NMIM team include data capture platforms (ELN, Registration systems, LIMS, Logistics, Assay Data, MDM), Data Architecture (Responsible for integrating both out internal and external data to ensure that the right data is available to UCB scientists) and a team of data scientists providing bespoke tools and visualizations aimed at providing insights to UCB scientists. Dr. Chapman has led the IT aspects of a number of acquisitions including emerging technologies new to UCB. He has over 20 years’ experience working within the Pharmaceutical industry in a variety of Informatics and IT roles. He received his PhD in Chemistry from Warwick University; he transitioned to informatics during post-doctoral research at Cambridge University as part of the CLIC consortium. Dr. Chapman was elected PRISME Forum (https://www.prismeforum.org) Chair at the November 2018 PRISME Forum Business Meeting.